Mona Fiuzat

Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure

Assessment of Frailty in Patients with Heart Failure: A New Heart Failure Frailty Score Developed by Delphi Consensus

Artificial Intelligence in Cardiovascular Clinical Trials

Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society

Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies

Heart failure medical therapy and outcomes in patients undergoing transcatheter mitral valve repair for secondary mitral regurgitation: a TVT Registry analysis across 449 US centers

Abstract 12936: Quality of Life Assessments as Inclusion Criteria in Heart Failure Clinical Trials

Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials

Improving Enrollment of Underrepresented Racial and Ethnic Populations in Heart Failure Trials

Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review

Functional and Symptomatic Clinical Trial Endpoints

In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction

Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium

Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials

Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel from the Heart Failure Collaboratory and Academic Research Consortium

The Hospital Readmissions Reduction Program

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials

Heart Failure With Preserved Ejection Fraction Expert Panel Report

The Role of Angiotensin Receptor–Neprilysin Inhibitors in Cardiovascular Disease—Existing Evidence, Knowledge Gaps, and Future Directions

Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

Cardiovascular Outcomes With Minute Ventilation–Targeted Adaptive Servo-Ventilation Therapy in Heart Failure

Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure

Abnormal Liver Function Tests in Acute Heart Failure: Relationship with Clinical Characteristics and Outcome in the PROTECT Study

Tolvaptan in Patients Hospitalized With Acute Heart Failure

Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction

Decongestion in Acute Heart Failure

Rationale and Design of the GUIDE-IT Study

Charting a Roadmap for Heart Failure Biomarker Studies

Acute Heart Failure in Elderly Patients: Worse Outcomes and Differential Utility of Standard Prognostic Variables. Insights from the PROTECT Trial